The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial assessing safety and preliminary efficacy of high-dose intravenous ascorbic acid in patients with TET2-mutant clonal cytopenias of undetermined significance.
 
Zhuoer Xie
No Relationships to Disclose
 
Terra L. Lasho
No Relationships to Disclose
 
Jenna Fernandez
No Relationships to Disclose
 
Christy Finke
No Relationships to Disclose
 
Michelle Amundson
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Abhishek Avinash Mangaonkar
Research Funding - BMS (Inst)
 
Thomas E. Witzig
Honoraria - Curio Science; Curio Science (Inst)
Consulting or Advisory Role - Tornado Therapeutics
Research Funding - Acerta Pharma (Inst); Acrotech Biopharma (Inst); Celgene (Inst); Karyopharm Therapeutics (Inst); Kura Oncology (Inst)
Patents, Royalties, Other Intellectual Property - I am co-inventor on a patent application filed by Mayo Clinic and pending on the combination of CRM1 inhibitors with salicylates. Please note - simply filed - not even close to being granted. (Inst)
 
Mrinal Mahesh Patnaik
Research Funding - Kura Oncology (Inst); Stem Line Pharmaceuticals (Inst)